These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 13548430)
1. [Treatment of thromboembolism with pyrexal]. STAMM H; EICHENBERGER E Geburtshilfe Frauenheilkd; 1958 Apr; 18(4):451-61. PubMed ID: 13548430 [No Abstract] [Full Text] [Related]
2. Treatment of thrombo-embolic conditions with pyrexal. STAMM H; ANTALOCZI S Ann Chir Gynaecol Fenn Suppl; 1958; 47(81):202-10. PubMed ID: 13606462 [No Abstract] [Full Text] [Related]
3. [Pyretotherapy in ophthalmology; observation of 60 cases treated with pyrexal]. AL SAADI AH; STUCCHI C Ophthalmologica; 1959 Jan; 137(1):51-61. PubMed ID: 13633197 [No Abstract] [Full Text] [Related]
4. Fibrinolytic treatment of thrombo-embolic diseases with purified bacterial pyrogens. MENEGHINI P Acta Haematol; 1958 Feb; 19(2):65-81. PubMed ID: 13520250 [No Abstract] [Full Text] [Related]
5. [Behavior of serum proteins in acute & chronic salpingo-oophoritis under pyrexal therapy. II. Clinical & experimental study on the behavior of alpha 2-globulin and also protein-bound polysaccharides & neuraminic acid in serum]. PROBST V; SCHUMACHER G; GRAF H Medizinische; 1958 Sep; 38():1482-8. PubMed ID: 13589529 [No Abstract] [Full Text] [Related]
6. [The treatment of ureteral stenosis with bacterial pyrogens]. Mebel' M; Gottshalk U Urol Nefrol (Mosk); 1965; 30(6):3-6. PubMed ID: 5873997 [No Abstract] [Full Text] [Related]
7. [Biological effect of highly purified bacterial pyrogens in intravenous irritant therapy]. SCHUMACHER G Hippokrates; 1959 Jun; 30(11):428-30. PubMed ID: 13672528 [No Abstract] [Full Text] [Related]
8. [Value of highly purified bacterial lipopolysaccharides in the treatment of adnexitis]. FRICKE H; PROBST V; SCHUMACHER G Schweiz Med Wochenschr; 1958 Jul; 88(28):691-8. PubMed ID: 13580182 [No Abstract] [Full Text] [Related]
9. [Results of treatment of neurodermatitis with Pyrogenal]. Borzov MV; Kossovskaia OIa Vestn Dermatol Venerol; 1968 Jan; 42(1):68-9. PubMed ID: 5741218 [No Abstract] [Full Text] [Related]
10. [Prevention and treatment of thromboembolism; kit for acute cases]. PEDERSEN BS Ugeskr Laeger; 1955 Jan; 117(3):77-9. PubMed ID: 14374034 [No Abstract] [Full Text] [Related]
11. [Further results on the sequels of thromboembolism after causal and conservative treatment]. THOMASCHECK G Zentralbl Gynakol; 1956 Sep; 78(36):1405-16. PubMed ID: 13393594 [No Abstract] [Full Text] [Related]
12. [HEILMEYER'S TEST OF INTRADERMAL REACTION TO PYREXAL AS A TEST OF INFLAMMATORY ACTIVITY]. LUCCHELLI PD; ROSSINI A Gazz Int Med Chir; 1963 Dec; 67():SUPPL:3891+. PubMed ID: 14177616 [No Abstract] [Full Text] [Related]
13. [Studies on quantitatively studied pyrexal erythema in some dermatoses]. HEITE HJ; KLEINHANS D Arch Klin Exp Dermatol; 1961; 212():460-6. PubMed ID: 13713030 [No Abstract] [Full Text] [Related]
14. [Pelentan treatment of thromboembolism following a gynecological operation]. TREIT S; SZINNYAI M; VARJASI F; HUNKA R Magy Noorv Lapja; 1954 Sep; 17(5):296-8. PubMed ID: 14369051 [No Abstract] [Full Text] [Related]
15. [Prevention and treatment of thromboembolism on the principle of evidence-based medicine]. Hu DY; Sun YH Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2163-8. PubMed ID: 16321174 [No Abstract] [Full Text] [Related]
16. Emerging themes in the treatment of venous thromboembolism. Weitz JI Thromb Haemost; 2006 Sep; 96(3):239-41. PubMed ID: 16953262 [No Abstract] [Full Text] [Related]
17. [Use of pyrogenal in hypertensive patients]. Patskikh EV Vrach Delo; 1965 Jan; 1():121-2. PubMed ID: 5853961 [No Abstract] [Full Text] [Related]
18. [Pyretotherapy of the nephrotic syndrome]. REUBI F Ther Umsch; 1958 Dec; 15(12):320-1. PubMed ID: 13625178 [No Abstract] [Full Text] [Related]
19. [Experience in treating thromboembolism at the University Gynecological Clinic in Berlin]. RASSLER R Ther Ggw; 1955 May; 94(5):173-6. PubMed ID: 14396835 [No Abstract] [Full Text] [Related]